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Among the MAPK signaling pathways, JNKs and p38-MAPKs were identified to be activated in response to a variety of cellular and environmental stresses such as changes in osmolarity, DNA damage, heat shock, ischemia, cytokines, UV irradiation, or oxidative stress. [2] [3] [4] JNKs are directly activated by the two upstream kinases MKK4 and MKK7. Once activated, JNKs regulate gene transcription via phosphorylation of transcription factors, such as Jun. [2] [3] [4] [5] In contrast, p38-MAPKs are activated by MKK3 and MKK6. 2, 4 These two stress pathways participate in many different intracellular signaling cascades that control a spectrum of cellular processes, including proliferation, differentiation, or apoptosis.
Although JNK and p38-MAPK have the same phylogenic origin, 1 it is not known why two genetically independent stress-signaling pathways have evolved in evolution. Here we show that the two stress pathways, MKK7-JNK and MKK3/6-p38-MAPK, oppositely control cellular proliferation, regeneration, senescence, and oncogenic transformation, and that qthe balance between two pathways determines cell fates in response to a variety of stress stimuli.
Results
Antagonistic effect of JNK and p38-MAPK pathways in cell proliferation. Mouse embryonic fibroblasts (MEFs) isolated from mkk7 mutant embryos display impaired JNK and Jun activation, reduced cell proliferation, premature senescence, as well as augmented susceptibility to stressinduced aging ( Figure 1 and Wada et al. 6 ). In contrast, activation of p38-MAPK can also result in premature senescence of MEFs, 7 whereas pharmacological p38-MAPK inhibition induces increased cell proliferation, 8 To assess functional hierarchies and potential molecular crosstalks between the JNK and p38-MAPK stress pathways in cell fate decisions, we tested the effects of p38-MAPK modulation in mkk7 À/À MEFs. Surprisingly, inhibition of p38-MAPKa/b using the selective inhibitor SB202190 restored the proliferation of mkk7-deficient MEFs to that of MKK7-expressing control cells (Figure 1a ). To further confirm whether the reversal effects of cell proliferation are indeed p38-MAPK dependent, we introduced dominant-negative forms of MKK3 and MKK6 (MKK3-DN and MKK6-DN) into mkk7 À/À MEFs to genetically inactivate p38-MAPK activity. Similar to SB202190, both MKK3-DN and MKK6-DN restored cell proliferation in mkk7-deficient cells (Figure 1b) . Expression of MKK3-DN and MKK6-DN in MEFs inhibited UV-induced p38-MAPK activation as measured by ATF2 phosphorylation, but had no substantial effect on UV-induced JNK activation (Supplementary Figure 1a) . Thus, inhibition of the p38-MAPK pathway can rescue the proliferative defect observed in mkk7 À/À MEFs.
JNK and p38-MAPK antagonistically control cellular senescence. To examine whether these antagonistic effects are limited to cell proliferation, we examined other MKK7-JNK-dependent cell fate responses such as senescence. 6 Treatment of mkk7 À/À MEFs with the selective p38-MAPKa/b inhibitor SB202190, as well as overexpression of MKK3-DN and MKK6-DN indeed Figure 1e ). These results show that MKK7-JNK and MKK3/6-p38-MAPK pathways play opposite roles in multiple cell fate responses: inactivation of the MKK7-JNK pathway results in defective proliferation and premature senescence; in contrast, inhibition of MKK3/6-p38-MAPK pathway triggers cell proliferation and markedly suppresses the cellular aging response. Importantly, inhibition of the p38-MAPK pathway allows mkk7-null cells to exit the cell cycle block and rescues mkk7 À/À MEFs from a premature aging response in response to environmental stress.
The JNK and p38-MAPK stress pathways balance oncogenic transformation. It has been shown that cell proliferation, senescence, and cancer are closely linked at the molecular level.
9 Both MKK7-JNK-Jun as well as MMK3/ MMK6-p38-MAPK signaling have been implicated in multiple cancers in humans.
2,10 Since MKK7-JNK and MKK3/6-p38-MAPK pathways exhibit antagonistic roles in cell proliferation and senescence, we speculated that both pathways may also exhibit opposing functions in oncogenic transformation. As reported previously, 11 MEFs can be transformed by ectopic overexpression of oncogenic Ras À/À MEFs. To extend these findings to another oncogenic cancer model, we examined the involvement of the MKK7-JNK and p38-MAPK pathways in Tpr-Met-induced cell transformation. 12 Similar to Ras 12V and c-myc, overexpression of oncogenic Tpr-Met triggered transformation in control MEFs, but to a much lesser extent in mkk7-deficient cells. Importantly, suppression of the p38-MAPK via MKK6-DN again promoted cell transformation in both control MEFs and restored oncogenic transformation in mkk7-deficient MEFs (Figure 2c) . These results using different oncogenes show that the MKK7-JNK pathway is critical for cellular transformation, whereas p38-MAPK signaling negatively regulates oncogene-induced cellular transformation.
CDC2
is a potential target for molecular antagonisms. How can activation of two different cellular stress pathways result in opposite effects on cell cycle progression, senescence, or transformation in MEFs? We have recently identified the cell cycle kinase CDC2 as a molecular target for the MKK7-JNK signaling pathway in MEFs that links environmental stress and developmental cues to cell proliferation and senescence. 6 Biochemically, CDC2 has also been identified as a downstream target for the p38-MAPK pathway. 13 We therefore speculated that a molecular antagonism between these two different stresssignaling pathways might converge on CDC2. Since mkk7-deficient MEFs show reduced CDC2 expression and impaired CyclinB1 associated CDC2 kinase activity depending on the cell passage, 6 we examined whether CyclinB1 associated CDC2 kinase activity can be rescued by inhibition of the p38-MAPK pathway. Whereas CDC2 expression and total CDC2 kinase activity were indeed markedly reduced in mkk7-null MEFs, inhibition of p38-MAPK resulted in increased CDC2 activity, without obvious effects on CDC2 expression (Figure 3a) . Inhibition of p38-MAPK also resulted in increased CDC2 activity in mkk7
MEFs, suggesting that p38-MAPK can repress CDC2 activation even in the presence of MKK7 expression (Supplementary Figure 1b) . In the same experimental system, we did not observe substantially altered CyclinD1-associated Cdk4 activity (Figure 3b ). These results suggest that antagonistic regulation of CDC2 by MKK7-JNK and MKK3/6-p38 may be one of checkpoints by which different stress-signaling pathways control cell fate in MEFs.
Antagonism of the JNK and p38-MAPK pathways in hepatocyte proliferation and liver regeneration in vivo. To determine whether the observed molecular antagonism between MKK7-JNK and p38-MAPK pathways also occurs in other cell types, we analyzed mouse embryonic hepatoblasts. Inactivation of MKK7 in mice leads to embryonic lethality due to defective fetal liver (Figure 4a ). To determine whether functional antagonism between the MKK7-JNK and p38-MAPK pathways is limited to embryonic cells, that is, MEFs and hepatoblasts, or if such antagonism is also operational in adult tissue, liver regeneration (as stress) after partial hepatectomy was examined. Partial hepatectomy in wildtype animals triggers liver regeneration due to rapid re-entry of hepatocytes into the cell cycle, as determined by Ki67 staining (Figure 4b ). Jun is a critical downstream target of MKK7-JNK: overexpression of Jun is sufficient to rescue defective proliferation and premature senescence in mkk7 À/À MEFs, 6 and inactivation of jun in adult mouse hepatocytes using Mx-Cre Jun flox alleles results in defective hepatocyte proliferation (Figure 4b and Behrens et al.
14 ). Since p38-MAPKa is the predominant isoform expressed in liver (http://www.genecards.org), we therefore generated adult mice with conditional deletion of both Jun and p38-MAPKa (Mx-Cre;Jun flox/flox p38-MAPKa flox/flox ) in hepatocytes. Intriguingly, in vivo hepatocyte proliferation was rescued in mice lacking both jun and p38-MAPKa (Figure 4b ). We next analyzed CyclinB1-associated CDC2 kinase activity. Genetic deletion of both jun and p38-MAPKa resulted in strong induction of CyclinB1-associated kinase activity following partial hepatectomy ( Supplementary Figure 2a and b) . Of note, previous experiments have also reported reduced CyclinB1-associated kinase activity in jun mutant mice.
14 Consistent among all samples analyzed, markedly enhanced CyclinB1-associated CDC2 kinase activity was observed in the absence of p38-MAPK (Supplementary Figure 2, and not shown). These results show that the two stress pathways exert antagonistic effects on cell fates in embryonic and adult tissues and multiple cell types.
Discussion
Our data indicate that the two distinct stress-signaling pathways, MKK3/MKK6-p38-MAPK versus MKK7-JNK, can exert opposite effects on cell cycle progression, cellular senescence, oncogenic transformation, and adult liver regeneration (Figure 4c) . In response to environmental stress and oncogenic signals, the MKK7-JNK pathway promotes proliferation, transformation, and regeneration and prevents premature senescence. By contrast, activation of MKK3/6-p38-MAPK pathway antagonizes these MKK7-JNK functions. Although the roles of each MKK3/6-p38-MAPK and MKK7-JNK pathway in cell proliferation and senescence have been previously shown by us and other groups, 6 -8 the molecular cross-talks and the balance of the both pathways are not well described. Our data in fibroblasts and hepatocytes suggest that the two distinct stress-signaling pathways can both act on CDC2 with opposite effects. Regulation of CDC2 by MKK7-JNK and MKK3/6-p38 might be one mechanism by which stress signaling is coupled to cancer, cell cycle progression, or senescence. However, antagonistic cell fate regulations by the two stress pathways most likely also includes mechanisms other than CDC2, since many genes and proteins are regulated by MKK7-JNK-Jun and MKK3/6-p38-MAPKs. 2 In conclusion, our results show that the stress kinase p38-MAPK pathway antagonizes MKK7-JNK functions in terms of cellular proliferation, senescence, oncogenic transformation, and liver regeneration. These data indicate that the balance between MKK7-JNK and MKK3/6-p38-MAPK signaling determines cell fate decisions in response to environmental and developmental stress in cancer, aging, and tissue regeneration.
Materials and Methods
Mice. mkk7-deficient MEFs were obtained as described. 6 To disrupt the murine Jun and p38-MAPKa in liver, mice carrying jun flox (Behrens et al. 14 ) and p38-MAPKa flox (Engel et al. 15 ) alleles were crossed to Mx1-Cre transgenic mice. The Cre transgene was induced in adult mice upon injections of polyinosinicpolycytidylic ribonucleic acid as described previously.
14 Deletions of Jun and p38-MAPKa were confirmed by Western blot using Jun-and p38-MAPK-specific antibodies (Cell Signaling, data not shown). Partial hepatectomy was performed as described previously. 16 Mouse experiments were performed according to institutional guidelines.
MEF cultures. MEFs were prepared from E11.5. embryos and maintained in DMEM with 10% FCS. Since mkk7 þ / þ and mkk7 þ /À MEFs behave equally in our experimental systems, mkk7 þ /À MEFs were used as controls. Cell proliferation in MEFs was determined using WST-1 (Roche). HA-tagged dominant-negative forms of MKK3 and MKK6 that carry inactivating AL mutations in their respective phosphorylation sites attenuate p38-MAPK activities, but not JNK activities in the presence of sorbitol stimuli.
17 Dominant-negative MKK3 and MKK6 were ligated into a pBabe-puro vector to generate the pBabe-puro-MKK3DN and pBabe-puro-MKK6DN expression constructs. The expression of MKK3DN and MKK6DN was confirmed using an anti-HA antibody (Sigma; Supplementary Figure 1a) . For ectopic gene expression in MEFs, the retroviral vectors pBabe-puro as control, pBabe-puro-MKK7 6 , pBabe-puro-MKK3DN, or pBabe-puro-MKK6DN were transfected into phoenix-E packaging cells. MEFs were cultured in the supernatant of the packaging cells containing 5 mg/ml polybrene for 1 day and selected with 2.5 mg/ml puromycin for 2 days followed by 2 days of recovery. Empty pBabe-puro as control vector did not show any detectable effect on the phenotype of MEFs. SB202190 (Calbiochem) or the solvent DMSO were added into cultures as indicated in the figure legends. If not stated otherwise, MEFs at passages 4-5 were used in all experiments. To detect senescent cells, SA-b-gal staining was performed (Cell Signaling). It should be noted that all SA-b-gal-positive cells had the typical flattened cell morphology characteristic of senescent cells. 18 Oncogenic transformation. MEFs were transformed with oncogenic Ras-V12 plus c-Myc or with oncogenic Tpr-Met using the retroviral vector pBabe as described above. Three thousand cells at passage 4 were plated on six-well plates and cultured for 21 days. The resultant foci were stained with Coomassie brilliant blue, and the numbers of foci were determined.
Kinase assays. To detect Cyclin-associated kinase activities, liver samples or MEFs (passages 2-4) were homogenized in lysis buffer containing 50 mM Tris-HCl (7.5), 150 mM NaCl, 1 mM EDTA, 1 mM DTT, 0.1% Tween-20, 10% glycerol, 1 mM NaF, 0.2 mM Na 3 VO 4 , and protease inhibitor cocktail (Roche), and CyclinD1 and CyclinB1 were immunoprecipitated from the supernatants at 41C using specific antibodies (Santa Cruz). Kinase activities were determined using GST-Rb for CyclinD1 (Santa Cruz) and HistoneH1 for CyclinB1 (Roche) as substrates in the presence of [g-32 P]ATP. To detect JNK and p38-MAPK kinase activities, JNK and p38-MAPK were immunoprecipitated from MEF lysates using specific antibodies (Santa Cruz and Cell Signaling, respectively). Kinase activities were determined using GST-Jun and GST-ATF2 as substrates, in the presence of [g-32 P]ATP. Protein expression levels were determined using antibodies specific to CyclinB1, CyclinD1, Cdk4 (Santa Cruz), JNK, CDC2 (Cell Signaling), and actin (Sigma).
